http://opendata.unex.es/recurso/educacion/universidad/personal/a88a102f8b7f60cbb1770369d8a517a5-jose-augusto-garcia-agundez-perez-coca
Relations
- teach:teacherOf
- ou:tienePublicacion
- 7th drug hypersensitivity meeting: part one
- A Nonsynonymous FCER1B SNP is Associated with Risk of Developing Allergic Rhinitis and with IgE Levels
- A family study of DRD3 rs6280, SLC1A2 rs3794087 and MAPT rs1052553 variants in essential tremor
- A genome-wide association study identifies colorectal cancer susceptibility loci on chromosomes 10p14 and 8q23.3
- A polymorphism located at an ATG transcription start site of the heme oxygenase-2 gene is associated with classical Parkinson's disease
- Acetylator status and N-acetyltransferase 2 gene polymorphisms; Phenotype-genotype correlation with the sulfamethazine test
- Acquired resistance to the anticancer drug paclitaxel is associated with induction of cytochrome P450 2C8
- Acute Effects of 1‐Methyl‐4‐Phenyl‐1, 2, 3, 6‐Tetrahydropyridine in a Model of Rat Designated a Poor Metabolizer of Debrisoquine
- Advances in understanding genomic markers and pharmacogenetics of Parkinsons disease
- Alcohol consumption and risk for Parkinson’s disease: a systematic review and meta-analysis
- Alcohol dehydrogenase 2 genotype and allelic variants are not associated with the risk for essential tremor
- Alcohol dehydrogenase 2 genotype and risk for migraine
- Allergic reactions to metamizole: Immediate and delayed responses
- Alpha-Synuclein in Peripheral Tissues as a Possible Marker for Neurological Diseases and Other Medical Conditions
- Aminopyrine N-demethylase activity in human liver microsomes
- Aminopyrine N-demethylase activity in human liver microsomes.
- Aminopyrine metabolism in man: The acetylation of aminoantipyrine cosegregates with acetylation of caffeine
- An Update on the Role of Nitric Oxide in the Neurodegenerative Processes of Parkinson's Disease.
- An association study between heme oxygenase-1 genetic variants and Parkinson’s disease
- An update on the neurochemistry of essential tremor
- An update on the pharmacogenomics of NSAID metabolism and the risk of gastrointestinal bleeding
- An update on the pharmacogenetic considerations when prescribing dopamine receptor agonists for Parkinson’s disease
- An update on the role of nitric oxide in the neurodegenerative processes of parkinson's disease
- Analysis of a non-synonymous single nucleotide polymorphism of the human diamine oxidase gene (ref. SNP ID: Rs1049793) in patients with Crohn's disease
- Analysis of midazolam and metabolites in plasma by high-performance liquid chromatography: Probe of CYP3A
- Analysis of the functional polymorphism in the cytochrome P450 CYP2C8 gene rs11572080 with regard to colorectal cancer risk
- Anti-Parkinson's disease drugs and pharmacogenetic considerations
- Anti-inflammatory effects of amantadine and memantine: Possible therapeutics for the treatment of covid-19?
- Aradyal: The spanish multidisciplinary research network for allergic diseases
- Arylamine N-acetyltransferase 2 genotypes in a Mexican population
- Assessment of cumulative evidence for the association between glutathione S-transferase polymorphisms and lung cancer: application of the Venice interim guidelines.
- Assessment of nonsteroidal anti-inflammatory drug-induced hepatotoxicity
- Association between the oxidative polymorphism and early onset of Parkinson's disease
- Association between Vitamin D receptor rs731236 (Taq1) polymorphism and risk for restless legs syndrome in the Spanish caucasian population
- Association between the rs1229984 polymorphism in the alcohol dehydrogenase 1B gene and risk for restless legs syndrome
- Association between the missense alcohol dehydrogenase rs1229984T variant with the risk for Parkinson’s disease in women
- Association between restless legs syndrome and other movement disorders
- Association between endothelial nitric oxide synthase (NOS3) rs2070744 and the risk for migraine
- Association between restless legs syndrome and peripheral neuropathy: A systematic review and meta-analysis
- Association between LAG3/CD4 gene variants and risk of Parkinson's disease
- Association between LAG3/CD4 Genes Variants and Risk for Multiple Sclerosis
- Association of CYP2C9 genotypes leading to high enzyme activity and colorectal cancer risk
- Association of Essential Tremor with Novel Risk Loci: A Genome-Wide Association Study and Meta-analysis
- Association study among candidate genetic polymorphisms and chemotherapy-related severe toxicity in testicular cancer patients
- Asthma and allergic rhinitis associate with the rs2229542 variant that induces a p.Lys90Glu mutation and compromises AKR1B1 protein levels
- Asthma and rhinitis induced by selective immediate reactions to paracetamol and non-steroidal anti-inflammatory drugs in aspirin tolerant subjects
- Biological fluid levels of iron and iron-related proteins in Parkinson’s disease: Review and meta-analysis
- C282Y and H63D mutations of HFE gene in patients with advanced alcoholic liver disease
- COMT gene and risk for Parkinson's disease: A systematic review and meta-analysis
- CYP2A6 gene polymorphism and risk of liver cancer and cirrhosis
- CYP2C19 polymorphism and risk for essential tremor
- CYP2D6 gene amplification and the risk of acute myeloblast leukemia
- CYP2D6 genes and risk of liver cancer
- CYP2D6 genotypes in Spanish women with breast cancer
- CYP2D6, NAT2 and CYP2E1 genetic polymorphisms in nonagenarians
- CYP2W1 variant alleles in Caucasians and association of the CYP2W1 G541A (Ala181Thr) polymorphism with increased colorectal cancer risk
- CYP3A4 variant alleles in white individuals with low CYP3A4 enzyme activity
- Caffeine demethylase activity in human and Dark Agouti rat liver microsomes: Comparison with aminopyrine N-demethylase activity
- Cerebrospinal and blood levels of amino acids as potential biomarkers for Parkinson’s disease: review and meta-analysis
- Cerebrospinal and blood levels of amino acids as potential biomarkers for Parkinson's disease: review and meta-analysis. Response to letter to the editor by Zheng et al.
- Cerebrospinal fluid biochemical studies in patients with Parkinson's disease: Toward a potential search for biomarkers for this disease
- Changes Induced by Ovariectomy on the Acute Effects of 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine in a Model of Rat Poor Metabolizer of Debrisoquine
- Changes at the CYP2C locus and disruption of CYP2C8/9 linkage disequilibrium in patients with essential tremor
- Characteristics of subjects experiencing hypersensitivity to non-steroidal anti-inflammatory drugs: Patterns of response
- Clarifying haplotype ambiguity of NAT2 in multi-national cohorts
- Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for CYP2D6 genotype and use of ondansetron and tropisetron
- Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for CYP2C19 and Voriconazole Therapy
- Clinical Pharmacogenetics Implementation Consortium Guideline (CPIC) for CYP2C9 and Nonsteroidal Anti-Inflammatory Drugs
- Clinical pharmacogenomic testing of KRAS, BRAF and EGFR mutations by high resolution melting analysis and ultra-deep pyrosequencing
- Clinical pharmacogenomics for CYP2C8 and CYP2C9: General concepts and application to the use of NSAIDs
- Clinical pharmacogenomics in asthma therapy
- Clinical practice guidelines for translating pharmacogenomic knowledge to bedside. Focus on anticancer drugs
- Clinical use of biomarkers in drug metabolism and adverse drug reactions
- Coenzyme Q10 and Dementia: A Systematic Review
- Coenzyme Q10 and Parkinsonian Syndromes: A Systematic Review
- Common Endothelial Nitric Oxide Synthase Single Nucleotide Polymorphisms are not Related With the Risk for Restless Legs Syndrome
- Common UGT1A6 Variant Alleles Determine Acetaminophen Pharmacokinetics in Man
- Comparative in vitro and in vivo inhibition of cytochrome P450 CYP1A2, CYP2D6, and CYP3A by H<inf>2</inf>-receptor antagonists
- Copy number variation in ALOX5 and PTGER1 is associated with NSAIDs-induced urticaria and/or angioedema
- Correction to: Serum vitamin D, vitamin D receptor and binding protein genes polymorphisms in restless legs syndrome (Journal of Neurology, (2021), 268, 4, (1461-1472), 10.1007/s00415-020-10312-9)
- Current Drug Metabolism: Editorial
- Current and future neuropharmacological options for the treatment of essential tremor
- Current treatment options for rem sleep behaviour disorder
- Cytochrome P450 CYP2B6 genotypes and haplotypes in a Colombian population: Identification of novel variant CYP2B6 alleles
- Cytochrome P450 CYP2C9 Polymorphism and NSAID-Related Acute Gastrointestinal Bleeding
- Cytochrome P450 gene polymorphism and cancer
- Cytochrome P450 gene polymorphisms and variability in response to NSAIDs
- Debrisoquin oxidation genotype and susceptibility to lung cancer
- Debrisoquin oxidation genotype and susceptibility to lung cancer.
- Debrisoquine polymorphism: mechanism for very rapid oxidative phenotype
- Deep sequencing of prostaglandin-endoperoxide synthase (PTGE) genes reveals genetic susceptibility for cross-reactive hypersensitivity to NSAID
- Delta-amino-levulinic acid dehydratase gene and essential tremor
- Detection of genomic variations in BRCA1 and BRCA2 genes by long-range PCR and next-generation sequencing.
- Determination of aminopyrine and dipyrone metabolites in urine [2]
- Determination of aminopyrine, dipyrone and its metabolites in urine by high-performance liquid chromatography
- Detoxifying enzymes at the cross-roads of inflammation, oxidative stress, and drug hypersensitivity: Role of glutathione transferase P1-1 and aldose reductase
- Developments in pharmacogenetics, pharmacogenomics, and personalized medicine
- Diamine oxidase rs10156191 and rs2052129 variants are associated with the risk for migraine
- Dinucleoside tetraphosphatase from human blood cells. Purification and characterization as a high specific activity enzyme recognized by an anti-rat tetraphosphatase antibody
- Dopamine Receptor D3 (DRD3) genotype and allelic variants and risk for essential tremor
- Dopamine receptor 3(DRD3) polymorphism and risk for migraine
- Dopamine receptor D3 (DRD3) gene rs6280 variant and risk for restless legs syndrome
- Drug and xenobiotic biotransformation in the blood–brain barrier: A neglected issue
- Drug metabolism and hypersensitivity reactions to drugs
- Editorial on Cerebral endothelial and glial cells are more than bricks in the great Wall of the brain: Insights into the way the blood-brain barrier actually works (celebrating the centenary of Goldman’s experiments)
- Editorial: Biomarkers in drug hypersensitivity
- Editorial: Editor’s feature: negative findings in pharmacogenetics and pharmacogenomics
- Editorial: Insights in Pharmacogenetics and Pharmacogenomics: 2021
- Editorial: N-Acetyltransferases: Lessons learned from eighty years of research
- Editorial: NSAIDs Pharmacogenomics
- Effect of common NAT2 variant alleles in the acetylation of the major clonazepam metabolite, 7-aminoclonazepam.
- Effect of neurotransmitters on NADPH-cytochrome P450 reductase in vitro activity.
- Endothelial nitric oxide synthase (NOS3) rs2070744 polymorphism and risk for multiple sclerosis
- Enzymatic polymorphisms and pulmonary cancer | Polimorfismos enzimáticos y cáncer de pulmón.
- Erratum: Loss-of-function mutations in HPSE2 cause the autosomal recessive urofacial syndrome (The American Journal of Human Genetics (2010) 86 (957-962))
- Evaluation of immediate allergic reactions to dipyrone using dipyrone metabolites in basophil activation test.
- Exome-wide rare variant analysis in familial essential tremor
- Expression in human prostate of drug- and carcinogen-metabolizing enzymes: Association with prostate cancer risk
- Expression of paclitaxel-inactivating CYP3A activity in human colorectal cancer: Implications for drug therapy
- FCERI and histamine metabolism gene variability in selective responders to NSAIDS
- FUS: a putative biomarker for essential tremor raised by whole-exome sequencing analyses.
- Foreword
- Frequencies of 23 functionally significant variant alleles related with metabolism of antineoplastic drugs in the chilean population: Comparison with caucasian and asian populations
- Frequency of CYP2D6 allelic variants in multiple sclerosis
- Functional polymorphisms of xenobiotics metabolizing enzymes-a research topic
- Functionally active duplications of the CYP2D6 gene are more prevalent among larynx and lung cancer patients
- Fused in sarcoma (FUS) gene mutations are not a frequent cause of essential tremor in europeans
- GC gene polymorphism and unbound serum retinol-binding protein 4 are related to the risk of insulin resistance in patients with chronic hepatitis c: A prospective cross-sectional study
- GSTT1 and GSTM1 null genotypes may facilitate hepatitis C virus infection becoming chronic
- Gamma-Aminobutyric Acid (Gaba) Receptors Rho (Gabrr) Gene Polymorphisms and Risk for Migraine
- Gamma-aminobutyric acid (GABA) receptor rho (GABRR) polymorphisms and risk for essential tremor
- Gamma-aminobutyric acid GABRA4, GABRE, and GABRQ receptor polymorphisms and risk for essential tremor
- Gamma-aminobutyric acid (GABA) receptors GABRA4, GABRE, and GABRQ gene polymorphisms and risk for migraine
- Gamma-aminobutyric acid (GABA) receptors genes polymorphisms and risk for restless legs syndrome
- Gender and functional CYP2C and NAT2 polymorphisms determine the metabolic profile of metamizole
- Gene variants and haplotypes modifying transcription factor binding sites in the human cyclooxygenase 1 and 2 (PTGS1 and PTGS2) genes
- Genetic Variants in Cytosolic Phospholipase A2 Associated With Nonsteroidal Anti-Inflammatory Drug–Induced Acute Urticaria/Angioedema
- Genetic analysis of the NAT2 and CYP2D6 polymorphisms in white patients with non-insulin-dependent diabetes mellitus
- Genetic analysis of the arylamine N-acetyltransferase polymorphism in breast cancer patients
- Genetic basis for differences in debrisoquin polymorphism between a Spanish and other white populations
- Genetic basis for differences in debrisoquin polymorphism between a Spanish and other white populations.
- Genetic biomarkers of essential tremor: time to think outside of the box.
- Genetic determinants of metamizole metabolism modify the risk of developing anaphylaxis
- Genetic predisposition to acute gastrointestinal bleeding after NSAIDs use
- Genetic variability of histamine receptors in patients with Parkinson's disease
- Genetic variability of human diamine oxidase: Occurrence of three nonsynonymous polymorphisms and study of their effect on serum enzyme activity
- Genetic variability in CYP3A4 and CYP3A5 in primary liver, gastric and colorectal cancer patients
- Genetic variants of the arachidonic acid pathway in non-steroidal anti-inflammatory drug-induced acute urticaria
- Genetic variants of alcohol metabolizing enzymes and alcohol-related liver cirrhosis risk
- Genetically based impairment in CYP2C8- and CYP2C9-dependent NSAID metabolism as a risk factor for gastrointestinal bleeding: Is a combination of pharmacogenomics and metabolomics required to improve personalized medicine?
- Genetics of restless legs syndrome: An update
- Genome-wide association study raised biomarker SLC1A2 rs3794087 and essential tremor: is it too early to say?
- Genomic and pharmacogenomic biomarkers of parkinson's disease
- Genomic markers for essential tremor
- Glutathione S-transferase M1 and T1 genetic polymorphisms are not related to the risk of hepatocellular carcinoma: A study in the Spanish population
- Glutathione S-transferase m1 and t1 null genotypes increase susceptibility to idiosyncratic drug-induced liver injury
- Glutathione S-transferases μ1, θ1, π1 α1 and μ3 genetic polymorphisms and the risk of colorectal and gastric cancers in humans
- Glutathione S-transferase GSTT1 and GSTM1 allozymes: Beyond null alleles
- Glutathione S-transferases π1, α1 and μ3 genetic polymorphisms and the risk of hepatocellular carcinoma in humans
- Glutathione-S-transferase P1 polymorphism and risk for essential tremor
- H1-MAPT and the risk for familial essential tremor
- Hallevorden-Spatz disease
- Heme Oxygenase 1 and 2 Common Genetic Variants and Risk for Essential Tremor
- Heme Oxygenase-1 and 2 Common Genetic Variants and Risk for Multiple Sclerosis
- Heme Oxygenase-1 and 2 Common Genetic Variants and Risk for Restless Legs Syndrome
- Hereditary Coproporphyria Associated with the Q306X Mutation in the Coproporphyrin Oxidase Gene Presenting with Acute Ataxia.
- Hereditary Coproporphyria Associated with the Q306X Mutation in the
Coproporphyrin Oxidase Gene Presenting with Acute Ataxia
- Hereditary coproporphyria associated with the q306x mutation in the coproporphyrin oxidase gene presenting with acute ataxia
- High frequency of mutations related to impaired CYP2C9 metabolism in a Caucasian population
- High resolution mapping and mutation analyses of candidate genes in the urofacial syndrome (UFS) critical region
- High-resolution melting analysis of the common c.1905+1G>A mutation causing dihydropyrimidine dehydrogenase deficiency and lethal 5-fluorouracil toxicity
- Histamine pharmacogenomics
- Histamine-N-Methyl transferase polymorphism and risk for migraine: Research submission
- Histamine-N-methyl transferase polymorphism and risk for multiple sclerosis
- Human arylamine N-acetyltransferase type 2: Phenotypic correlation with genotype-a clinical perspective
- Hypersensitivity reactions to non-steroidal anti-inflammatory drugs
- Hypersensitivity reactions to nonsteroidal anti-inflammatory drugs: An update on pharmacogenetics studies
- Identification and characterisation of novel polymorphisms in the CYP2A locus: Implications for nicotine metabolism
- Identification and prevalence study of 17 allelic variants of the human NAT2 gene in a white population
- Identification of novel biomarkers for drug hypersensitivity after sequencing of the promoter area in 16 genes of the vitamin D pathway and the high-affinity IgE receptor
- Identification of subtypes of CYP2D gene rearrangements among carriers of CYP2D6 gene deletion and duplication
- Immediate hypersensitivity reactions to ibuprofen and other arylpropionic acid derivatives
- Immediate reactions to more than 1 NSAID must not be considered cross-hypersensitivity unless tolerance to asa is verified
- Impact of gastrointestinal tract variability on oral drug absorption and pharmacokinetics: An UNGAP review
- Impairment of rapid repetitive finger movements and visual reaction time in patients with essential tremor
- Importance of CYP2D6 genotype/activity testing and applications
- Improved analytical sensitivity reveals the occurrence of gender-related variability in diamine oxidase enzyme activity in healthy individuals
- Incorporation of pharmacogenomics into routine clinical practice: The clinical pharmacogenetics implementation consortium (CPIC) guideline development process
- Increased frequency of rapid acetylator genotypes in patients with brain astrocytoma and meningioma
- Increased risk for hepatocellular carcinoma in NAT2-slow acetylators and CYP2D6-rapid metabolizers
- Increased serum diamine oxidase activity in nonallergic patients with migraine
- Inflammatory factors and restless legs syndrome: A systematic review and meta-analysis
- Influence of Vitamin D-Related Gene Polymorphisms (CYP27B and VDR) on the Response to Interferon/Ribavirin Therapy in Chronic Hepatitis C
- Influence of age and gender in motor performance in healthy subjects
- Influence of cytochrome P450 CYP2C9 genotypes in lung cancer risk
- Influence of genetic admixture on polymorphisms of drug-metabolizing enzymes: Analyses of mutations on NAT2 and CYP2E1 genes in a mixed Hispanic population
- Inhibition of cytochrome P450 2C9 activity in vitro by 5-hydroxytryptamine and adrenaline
- Interaction of CYP2C8 and CYP2C9 genotypes modifies the risk for nonsteroidal anti-inflammatory drugs-related acute gastrointestinal bleeding
- Interethnic and intraethnic variability of CYP2C8 and CYP2C9 polymorphisms in healthy individuals
- Interindividual variability in ibuprofen pharmacokinetics is related to interaction of cytochrome P450 2C8 and 2C9 amino acid polymorphisms
- Interview: Perspective on the use of genomic biomarkers in the clinical setting
- LAG3/CD4 Genes Variants and the Risk for Restless Legs Syndrome
- LINGO1 and risk for essential tremor: Results of a meta-analysis of rs9652490 and rs11856808
- LINGO1 gene analysis in Parkinson's disease phenotypes
- LINGO1 rs9652490 and rs11856808 polymorphisms are not associated with risk for multiple sclerosis
- LINGO1 rs9652490 and rs11856808 are not associated with the risk of Parkinson's disease: Results of a meta-analysis
- Lack of Association between Common LAG3/CD4 Variants and Risk of Migraine
- Lack of Major Involvement of Common CYP2C Gene Polymorphisms in the Risk of Developing Cross-Hypersensitivity to NSAIDs
- Lack of association of LINGO1 rs9652490 and rs11856808 SNPs with familial essential tremor
- Latest perspectives in genetic risk factors for restless legs syndrome
- Leflunomide-induced acute hepatitis
- Loss-of-Function Mutations in HPSE2 Cause the Autosomal Recessive Urofacial Syndrome
- Lung cancer and mutations at the polymorphic NAT2 gene locus
- MAPT gene rs1052553 variant is not associated with the risk for multiple sclerosis
- MAPT1 gene rs1052553 variant is unrelated with the risk for restless legs syndrome
- Metabolic considerations of drugs in the treatment of allergic diseases
- Metabolism of aminopyrine and derivatives in man: In vivo study of monomorphic and polymorphic metabolic pathways
- Missense gamma-aminobutyric acid receptor polymorphisms are associated with reaction time, motor time, and ethanol effects in vivo
- Missense mutations in TENM4, a regulator of axon guidance and central myelination, cause essential tremor
- Mitochondrial superoxide dismutase and glutathione peroxidase in idiosyncratic drug-induced liver injury
- Modulation of CYP1A2 enzyme activity by indoleamines: Inhibition by serotonin and tryptamine
- Modulation of CYP2C9 activity and hydrogen peroxide production by cytochrome b <inf>5</inf>
- Modulation of GSTP1-1 oligomerization by electrophilic inflammatory mediators and reactive drugs.
- Modulation of midazolam 1-hydroxylation activity in vitro by neurotransmitters and precursors
- Molecular analysis of the arylamine N-acetyltransferase polymorphism in a Spanish population
- Molecular analysis of the arylamine N-acetyltransferase polymorphism in a Spanish population.
- Molecular heterogeneity at the CYP2D gene locus in Nicaraguans: Impact of gene-flow from Europe
- Molecular interactions and implications of aldose reductase inhibition by pga1 and clinically used prostaglandins
- Molecular monitoring of patient response to painkiller drugs
- Motor performance in patients with restless legs syndrome
- Mutaciones C282Y y H63D del gen HFE en pacientes con hepatopatía alcohólica avanzada
- N-acetyltransferase 2 polymorphism is not related to the risk of advanced alcoholic liver disease
- N-acetyltransferase 2 polymorphisms and risk of anti-tuberculosis drug-induced hepatotoxicity in Caucasians
- N-acetyltransferase 2 (NAT2) genotype and colorectal carcinoma: Risk variability according to tumour site?
- N-acetyltransferase 2 single-nucleotide polymorphisms and risk of gastric carcinoma
- N-acetyltransferase 2 single-nucleotide polymorphisms and risk of gastric carcinoma
- NAT2 genotyping: Equilibrium between accuracy and feasibility in routine analyses
- NAT2 polymorphisms and risk for Parkinson’s disease: a systematic review and meta-analysis
- NQO1 gene rs1800566 variant is not associated with risk for multiple sclerosis
- NSAIDs-hypersensitivity often induces a blended reaction pattern involving multiple organs
- Neurochemical features of idiopathic restless legs syndrome
- Neurochemical features of rem sleep behaviour disorder
- Neurochemistry of idiopathic restless legs syndrome
- Neuronal nitric oxide synthase (nNOS, NOS1) rs693534 and rs7977109 variants and risk for migraine
- Neuronal nitric oxide synthase (nNOS, NOS1) rs693534 and rs7977109 variants and risk for restless legs syndrome
- New advances in the study of IgE drug recognition
- Next-Generation Sequencing of PTGS Genes Reveals an Increased Frequency of Non-synonymous Variants among Patients with NSAID-Induced Liver Injury
- No association of the SLC1A2 rs3794087 allele with risk for essential tremor in the Spanish population
- Nonsynonymous polymorphisms of histamine-metabolising enzymes in patients with Parkinson's disease
- Outcomes and Laboratory and Clinical Findings of Asthma and Allergic Patients Admitted With Covid-19 in a Spanish University Hospital
- Oxidative stress in skin fibroblasts cultures from patients with Parkinson's disease
- PITX3 and risk for Parkinson's disease: A systematic review and meta-analysis
- Paraoxonase 1 (PON1) polymorphisms and risk for essential tremor
- Paraoxonase 1 (PON1) polymorphisms and risk for migraine
- Paraoxonase 1 polymorphisms are not related with the risk for multiple sclerosis
- Particulate diadenosine 5′,5‴-P<sup>1</sup>,P<sup>3</sup>-triphosphate hydrolases in rat brain: two specific dinucleoside triphosphatases and two phosphodiesterase I-like hydrolases
- Perception of the usefulness of drug/gene pairs and barriers for pharmacogenomics in latin America
- PharmVar GeneFocus: CYP2D6
- PharmVar GeneFocus: CYP2C19
- PharmVar GeneFocus: CYP2C9
- PharmVar Tutorial on CYP2D6 Structural Variation Testing and Recommendations on Reporting
- Pharmacogenetic Allele Nomenclature: International Workgroup Recommendations for Test Result Reporting
- Pharmacogenetic factors affecting asthma treatment response. potential implications for drug therapy
- Pharmacogenomics in aspirin intolerance
- Pharmacogenomics in drug induced liver injury
- Pharmacogenomics of cyclooxygenases
- Pharmacogenomics of prostaglandin and leukotriene receptors
- Pharmacogenomics testing for type B adverse drug reactions to anti-infective drugs: The example of hypersensitivity to abacavir
- Pharmacogenomics testing for type B adverse drug reactions to anti-infective drugs: The example of hypersensitivity to abacavir
- Pharmacokinetic interaction of fluvoxamine and thioridazine in schizophrenic patients
- Photomutagenicity of chlorpromazine and its N-demethylated metabolites assessed by NGS
- Polimorfismos enzimáticos y cáncer de pulmón
- Polymorhisms in the transforming growth factor-β<inf>1</inf> gene (TGF-β<inf>1</inf>) and the risk of advanced alcoholic liver disease
- Polymorphic drug metabolism in anaesthesia
- Polymorphism is not associated with essential tremor
- Polymorphism of the TLR4 gene reduces the risk of hepatitis C virus-induced hepatocellular carcinoma
- Polymorphisms of histamine-metabolizing enzymes and clinical manifestations of asthma and allergic rhinitis
- Polymorphisms of human N-acetyltransferases and cancer risk
- Polymorphisms of the glutathione S-transferases mu-1 (GSTM1) and theta-1 (GSTT1) and the risk of advanced alcoholic liver disease
- Possible implications of doxycycline-rifampin interaction for treatment of brucellosis
- Predicting response to therapy in chronic hepatitis C: An approach combining interleukin-28B gene polymorphisms and clinical data
- Prevalence of CYP2D6 gene duplication and its repercussion on the oxidative phenotype in a white population
- Purification to homogeneity of rat liver dinucleoside tetraphosphatase by affinity elution with adenosine 5′-tetraphosphate
- Pyrazolones metabolites are relevant for identifying selective anaphylaxis to metamizole
- Recent advances in drug intolerance.
- Refinement of the basis and impact of common 11q23.1 variation to the risk of developing colorectal cancer
- Relation of IL28b gene polymorphism with biochemical and histological features in hepatitis C virus-induced liver disease
- Reply
- Response to the Letter to the Editor regarding Improved analytical sensitivity reveals the occurrence of gender-related variability in diamine oxidase enzyme activity in healthy individuals
- Rsa I polymorphism at the cytochrome P4502E1 locus is not related to the risk of alcohol-related severe liver disease
- RsaI polymorphism at the cytochrome P4502E1 locus and risk of hepatocellular carcinoma
- SLC1A2 rs3794087 variant and risk for migraine
- SLC1A2 rs3794087 variant and risk for essential tremor: A systematic review and meta-analysis
- Serum Trace Elements Concentrations in Patients with Restless Legs Syndrome
- Serum vitamin D, vitamin D receptor and binding protein genes polymorphisms in restless legs syndrome
- Severity of ulcerative colitis is associated with a polymorphism at diamine oxidase gene but not at histamine N-methyltransferase gene
- Sex and age-related differences in aminopyrine n-demethylase activity in DA- and wistar-strain rat liver microsomes. Effect of ovariectomy
- Single nucleotide polymorphisms and microsatellite alleles of tumor necrosis factor alpha and interleukin-10 genes and the risk of advanced chronic alcoholic liver disease
- Sleep Disorders and Sleep Problems in Patients With Tourette Syndrome and Other Tic Disorders: Current Perspectives
- Sleep Disorders in Patients with Essential Tremor
- Sleep Disorders in Patients with Choreic Syndromes
- Sleep disorders in essential tremor: Systematic review and meta-analysis
- Sleep disorders in tourette syndrome
- Slow allotypic variants of the NAT2 gene and susceptibility to early- onset Parkinson's disease
- TREM2 R47H variant and risk of essential tremor: A cross-sectional international multicenter study
- The Diamine Oxidase Gene Is Associated with Hypersensitivity Response to Non-Steroidal Anti-Inflammatory Drugs
- The Differential Effect of NAT2 Variant Alleles Permits Refinement in Phenotype Inference and Identifies a Very Slow Acetylation Genotype
- The GSTP1 gene variant rs1695 is not associated with an increased risk of multiple sclerosis
- The H63D mutation of the HFE gene is related to the risk of hepatocellular carcinoma
- The Relationship Between Parkinson’s Disease and Essential Tremor: Review of Clinical, Epidemiologic, Genetic, Neuroimaging and Neuropathological Data, . . .
- The effect of the cytochrome P450 CYP2C8 polymorphism on the disposition of (R)-ibuprofen enantiomer in healthy subjects
- The genetics of drug hypersensitivity reactions
- The nonsynonymous Thr105Ile polymorphism of the histamine N-methyltransferase is associated to the risk of developing essential tremor
- The potential of LINGO-1 as a therapeutic target for essential tremor
- The potential role of pharmacogenomics and biotransformation in hypersensitivity reactions to paracetamol
- The relationship between Parkinson's disease and essential tremor: review of clinical, epidemiologic, genetic, neuroimaging and neuropathological data, and data on the presence of cardinal signs of parkinsonism in essential tremor.
- The relationship between parkinson’s disease and essential tremor: Review of clinical, epidemiologic, genetic, neuroimaging and neuropathological data, and data on the presence of cardinal signs of parkinsonism in essential tremor
- The role of CYP2C19 polymorphism in the development of adverse effects to drugs and the risk for diseases
- The role of phase I and II genetic polymorphisms, smoking, alcohol and cancer family history, in the risk of developing testicular cancer
- The solute carrier family 1 (glial high affinity glutamate transporter), member 2 gene, SLC1A2, rs3794087 variant and assessment risk for restless legs syndrome
- Thr105Ile (rs11558538) polymorphism in the histamine N -methyltransferase (HNMT) gene and risk for Parkinson disease
- Thr105Ile (rs11558538) polymorphism in the histamine-1-methyl-transferase (HNMT) gene and risk for restless legs syndrome
- Toward a clinical practice guide in pharmacogenomics testing for functional polymorphisms of drug-metabolizing enzymes. Gene/drug pairs and barriers perceived in Spain
- Treatment options for idiopathic restless legs syndrome
- Trends in qualifying biomarkers in drug safety. Consensus of the 2011 meeting of the Spanish Society of Clinical Pharmacology
- Tryptamine: A possible endogenous substrate for CYP2D6
- Two common nonsynonymous paraoxonase 1 (PON1) gene polymorphisms and brain astrocytoma and meningioma
- Unraveling ambiguous NAT2 genotyping data
- Update on genetics of essential tremor
- Urinary bladder cancer in a girl with a slow-acetylator genotype and treated with sulphasalazine
- Urinary bladder cancer in a girl with a slow-acetylator genotype and treated with sulphasalazine (multiple letters) [2]
- Variability in ethanol biodisposition in whites is modulated by polymorphisms in the ADH1B and ADH1C genes
- Variability in histamine receptor genes HRH1, HRH2 and HRH4 in patients with hypersensitivity to NSAIDs
- Variability of the L-Histidine decarboxylase gene in allergic rhinitis
- Variability of the genes involved in the cellular redox status and their implication in drug hypersensitivity reactions
- Variants of CEP68 gene are associated with acute urticaria/angioedema induced by multiple non-steroidal anti-inflammatory drugs
- Vitamin D Receptor and Binding Protein Gene Variants in Patients with Essential Tremor
- Vitamin D deficiency and vitamin D therapy in chronic hepatitis C
- Vitamin D receptor and binding protein genes variants in patients with migraine
- Vitamin D3 Receptor (VDR) Gene rs2228570 (Fok1) and rs731236 (Taq1) Variants Are Not Associated with the Risk for Multiple Sclerosis: Results of a New Study and a Meta-Analysis
- [The H63D mutation in the HFE gene is related to the risk of hepatocellular carcinoma]
- ou:perteneceAGrupoInvestigacion
- ou:imparteDocenciaEnArea
- ou:adscritoACentro
- ou:adscritoADepartamento
Inverse Relations
Inverse Blank Nodes
